Tag: WALL STREET BEAT

April 9, 2019

Though Apple (NSDQ:AAPL) has only begun to step into the healthcare market, a group of Morgan Stanley analysts estimate the company’s opportunity in the U.S. healthcare market to be three times larger than the global smartphone market, according to a […]

March 4, 2019

Medtronic (NYSE:MDT) has registered for a new undisclosed debt offering based in the European Union, according to recently posted SEC filings. The company will look to offer a slew of new general unsecured senior notes in the funding round, according […]

March 1, 2019

Shares in AtriCure (NSDQ:ATRC) have fallen slightly today despite the medical device maker posting fourth quarter earnings that topped expectations on Wall Street. The Mason, Ohio-based company posted losses of $3.4 million, or 9¢ per share, on sales of $52.9 […]

February 26, 2019

Insulet (NSDQ:PODD) posted its fourth-quarter and full-year financial results yesterday after the markets closed, beating estimates on Wall Street. The Acton, Mass.-based company posted profits of $9.9 million, or 17¢ per share, on sales of $164.9 million for the three […]

February 25, 2019

Glooko announced this month that it’s teaming up to connect Novo Nordisk‘s (NYSE:NVO) insulin pens with the company’s diasend diabetes management solution. Novo Nordisk plans to launch its connected insulin pens, the NovoPen 6 and NovoPen Echo Plus, in early […]

February 19, 2019

Medtronic (NYSE:MDT) said today that it won breakthrough status from the FDA for its investigational personalized closed-loop insulin pump system. The company touted its technology as enabling automated insulin delivery in a real-time, adaptable and personalized fashion. Medtronic’s November acquisition […]

February 6, 2019

Shares in Boston Scientific (NYSE:BSX) have risen slightly this morning after the medical device maker posted fourth quarter and full year 2018 earnings that topped consensus on Wall Street. The Marlborough, Mass.-based company posted profits of $386 million, or 27¢ […]

February 5, 2019

Shares in Haemonetics (NYSE:HAE) have fallen nearly 10% today after the medical device maker posted fiscal year 2019 third quarter earnings that topped earnings per share estimates but missed sales consensus on Wall Street. The Braintree, Mass.-based company posted profits […]

January 31, 2019

GE Healthcare (NYSE:GE) shares got a bump today after the company topped the consensus forecast for its fourth-quarter sales and swung to black ink for the period, with its healthcare business posting modest bottom- and top-line gains. The stock rise […]

January 28, 2019

A subsidiary of California-based Accuray (NSDQ:ARAY) has entered a joint venture with a Chinese company to manufacture and sell radiology oncology systems in China, the companies said today. Accuray Asia Ltd. will work with Tianjin-based CNNC High Energy Equipment, a […]

January 23, 2019

Abbott (NYSE:ABT) stock is down about 2% at the opening of trading today after its fourth-quarter sales failed to meet analyst expectations. The Abbott Park, Ill.–based maker of medical device, pharmaceutical, nutrition and diagnostics products brought in about $7.765 billion […]

January 15, 2019

What were the trends that drove the biopharma and drug delivery markets in 2018? Many of 2018’s key trends revolved around increasing regulatory requirements. However, as the market continues to move toward more personalized medicine, such as cell and gene […]

January 3, 2019

Several medical device companies took hits yesterday after analysts on Wall Street downgraded their stocks, on a day when the major market indices each closed up a hair, and even medtech firms that enjoyed upgrades came under pressure. Globus Medical […]

December 26, 2018

Teva (NYSE:TEVA) said this week that the FDA approved its ProAir Digihaler device – a digital inhaler that uses sensors to connect to a companion mobile app for people with asthma and chronic obstructive pulmonary disease. The company’s device features […]

November 16, 2018

Boston Scientific (NYSE:BSX) said yesterday that it’s planning a three-year restructuring program that’s slated to cost at least $200 million. The Marlborough, Mass.-based medical device maker said it expects to maintain roughly the same number of workers, although there will […]

November 8, 2018

Insulet (NSDQ:PODD) said this week that it inked a deal with Samsung to develop an Omnipod insulin delivery system that would allow users to control their insulin pump therapy with a Galaxy smartphone. If approved, the system would be the […]

October 30, 2018

Profits for the healthcare business at GE rose despite flat sales growth for the third quarter, as the parent company posted a swing to red ink on a -$22 billion charge. The Boston-based industrial conglomerate reported healthcare profits of $861 […]

October 26, 2018

Inovio Pharmaceuticals (NSDQ:INO) reported today that its synthetic HIV vaccine, Pennvax-GP, demonstrated durable antibody and T cell immune responses throughout a Phase I trial. The company found that Pennvax-GP plasmids delivered intradermally with Inovio’s Cellectra device triggered equivalent or superior […]

October 24, 2018

Xeris Pharmaceuticals (NSDQ:XERS) said today that the FDA accepted its new drug application for a ready-to-use liquid glucagon rescue pen device. The company’s product is designed to treat severe hypoglycemia in people with diabetes. The FDA is slated to make […]

October 22, 2018

Royal Philips (NYSE:PHG) shares took hits in New York and London today after it reported lower-than-forecast sales and earnings figures. The Dutch healthcare conglomerate posted profits of €292 million, or €0.33 per share, on sales of €4.31 billion for the […]